Semaglutide is the most widely recognized
- Do not split, crush or chew the tablet
In patients with type 2 diabetes, semaglutide is reported to improve glycaemic control dose-dependently, decreasing HbA 1c levels by 1.7% (18.7 mmol/mol) vs 0.5% (5.5 mmol/mol) with placebo and 4.8 kg of weight loss vs 1.2 kg with placebo, relative to baseline
December 03, 2025 By Leigh Farmer Glucagon-like peptide-1 receptor agonists, better known as GLP-1s, are naturally made in our intestines after we eat a meal
Bone density and linear growth were not primary endpoints, a gap the pediatric endocrinology community has flagged repeatedly
Theyve been through large clinicals trials involving tens of thousands of patients, been approved by the FDA and been prescribed for diabetes for more than 20 years